U.S. Markets
US President Trump plans executive order splitting measles, mumps and rubella shots
StockNow breaking-news AI analysis
President Trump's plan to split the MMR vaccine increases regulatory risks for Merck (MRK), aligning with broader administration efforts led by RFK Jr. to scale back federal vaccination mandates.
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
